Business of Medicine
The action is part of the broader Trump administration initiative to lower the prices and out-of-pocket costs of prescription drugs.
Vermont’s good outcomes and low costs have the rest of the country green with envy.
Dermatologists and oncologists lose under the proposal, while ob.gyns. could see their payments increased.
Three other health entities made the lobbying Top 10 for the first half of 2018.
Drug prices in the United States have continued to rise and more than 80% of Americans say the government should take action.
The proposal would cut add-on payments for new drugs.
Many studies have shown that, although consumers desire a choice when making purchases, they get overwhelmed if they are presented with too many...
Site-neutral payments could save the government – and patients – money on every visit.
Daily News Podcast
And HIV infection may double patients’ stroke rate.